Paper6139399
The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
Bliddal H and 3 others. J Endocrinol Invest, 1983. Cited by 11 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment. Papers, record 6139399. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6139399
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenylyl Cyclases | Major topic |
| Antibodies | Major topic |
| Graves Disease | Major topic |
| Immunoglobulin G | Major topic |
| Thyroid Gland | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Carbimazole | |
| Female | |
| Humans | |
| Immunoglobulins, Thyroid-Stimulating | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Propylthiouracil |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,179,303 | Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. | J Clin Endocrinol Metab | 1969 | https://conductscience.org/library/papers/4179303 | PubMed |
| 2 | 6,128,089 | Production of non-stimulatory immunoglobulins that inhibit TSH binding in Graves' disease after radioiodine administration. | Clin Endocrinol (Oxf) | 1982 | https://conductscience.org/library/papers/6128089 | PubMed |
| 3 | 581,876 | Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities. | J Clin Endocrinol Metab | 1979 | https://conductscience.org/library/papers/581876 | PubMed |
| 4 | 90,689 | Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease? | J Endocrinol Invest | 1978 | https://conductscience.org/library/papers/90689 | PubMed |
| 5 | 385,703 | Pathogenesis of neonatal Graves' disease. | J Endocrinol Invest | 1978 | https://conductscience.org/library/papers/385703 | PubMed |
| 6 | 6,894,411 | Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves' disease. | Clin Endocrinol (Oxf) | 1980 | https://conductscience.org/library/papers/6894411 | PubMed |
| 7 | 2,856,871 | Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators. | Endocrinology | 1985 | https://conductscience.org/library/papers/2856871 | PubMed |
| 8 | 6,118,939 | A stable, reproducible radioreceptorassay for thyrotropin binding inhibiting immunoglobulins (TBII). | Scand J Clin Lab Invest | 1981 | https://conductscience.org/library/papers/6118939 | PubMed |
| 9 | 6,892,512 | Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study. | J Clin Endocrinol Metab | 1980 | https://conductscience.org/library/papers/6892512 | PubMed |
| 10 | 6,170,200 | Prognostic value of thyrotrophin binding inhibiting immunoglobulins (TBII) in longterm antithyroid treatment, 131I therapy given in combination with carbimazole and in euthyroid ophthalmopathy. | Acta Endocrinol (Copenh) | 1981 | https://conductscience.org/library/papers/6170200 | PubMed |
| 11 | 6,181,640 | Evidence of a correlation between thyrotrophin receptor binding inhibition and thyroid adenylate cyclase activation by immunoglobulins in Graves' disease before and during long-term antithyroid treatment. | Acta Endocrinol (Copenh) | 1982 | https://conductscience.org/library/papers/6181640 | PubMed |
| 12 | 668,152 | Human thyroid adenylate cyclase in non-toxic goitre: sensitivity to TSH, fluoride and thyroid stimulating immunoglobulins. | Clin Endocrinol (Oxf) | 1978 | https://conductscience.org/library/papers/668152 | PubMed |
| 13 | 581,875 | Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. | J Clin Endocrinol Metab | 1979 | https://conductscience.org/library/papers/581875 | PubMed |
| 14 | 68,278 | Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease. | Lancet | 1977 | https://conductscience.org/library/papers/68278 | PubMed |
| 15 | 218,990 | Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders. | J Clin Endocrinol Metab | 1979 | https://conductscience.org/library/papers/218990 | PubMed |
| 16 | 6,247,656 | Carbimazole and the autoimmune response in Graves' disease. | N Engl J Med | 1980 | https://conductscience.org/library/papers/6247656 | PubMed |
| 17 | 6,118,213 | Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease. | Clin Endocrinol (Oxf) | 1981 | https://conductscience.org/library/papers/6118213 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6139399
GET https://conductscience.org/api/papers/v1/6139399/authors